Received Jun 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | BL473 | — |
a patient was given another dose of AREXVY vaccine today; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 63-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number BL473, expiry date 13-OCT-2026) for prophylaxis. Concomitant products included RSV VACCINE PROT. SUBUNIT PREF3 (AREXVY). On 06-JUN-2025, the patient received the 2nd dose of Arexvy. On 06-JUN-2025, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: a patient was given another dose of AREXVY vaccine today). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 06-JUN-2025 Licensed Practical Nurse called to report a patient was given another dose of Arexvy vaccine today, which led to Extra dose administered. First dose was administered 21-03-2025. Licensed practical nurse wanted to know if there as any safety concern or guidance about this situation. No further information was obtained in this call. The reporter was consented to follow up.
AREXVY